Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European … BA Ference, HN Ginsberg, I Graham, KK Ray, CJ Packard, E Bruckert, ... European heart journal 38 (32), 2459-2472, 2017 | 3498 | 2017 |
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of … BG Nordestgaard, MJ Chapman, SE Humphries, HN Ginsberg, L Masana, ... European heart journal 34 (45), 3478-3490, 2013 | 3107 | 2013 |
Lipoprotein (a) as a cardiovascular risk factor: current status BG Nordestgaard, MJ Chapman, K Ray, J Borén, F Andreotti, GF Watts, ... European heart journal 31 (23), 2844-2853, 2010 | 2205 | 2010 |
Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications I Tabas, KJ Williams, J Borén Circulation 116 (16), 1832-1844, 2007 | 1874 | 2007 |
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management MJ Chapman, HN Ginsberg, P Amarenco, F Andreotti, J Borén, ... European heart journal 32 (11), 1345-1361, 2011 | 1659 | 2011 |
Subendothelial retention of atherogenic lipoproteins in early atherosclerosis K Skålén, M Gustafsson, EK Rydberg, LM Hultén, O Wiklund, TL Innerarity, ... Nature 417 (6890), 750-754, 2002 | 1436 | 2002 |
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European … J Boren, MJ Chapman, RM Krauss, CJ Packard, JF Bentzon, CJ Binder, ... European heart journal 41 (24), 2313-2330, 2020 | 1199 | 2020 |
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on … M Cuchel, E Bruckert, HN Ginsberg, FJ Raal, RD Santos, RA Hegele, ... European heart journal 35 (32), 2146-2157, 2014 | 1149 | 2014 |
Overproduction of very low–density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome M Adiels, SO Olofsson, MR Taskinen, J Borén Arteriosclerosis, thrombosis, and vascular biology 28 (7), 1225-1236, 2008 | 1032 | 2008 |
Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment A Wiegman, SS Gidding, GF Watts, MJ Chapman, HN Ginsberg, M Cuchel, ... European heart journal 36 (36), 2425-2437, 2015 | 937 | 2015 |
Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points—a joint … BG Nordestgaard, A Langsted, S Mora, G Kolovou, H Baum, E Bruckert, ... European heart journal 37 (25), 1944-1958, 2016 | 880 | 2016 |
Overproduction of large VLDL particles is driven by increased liver fat content in man M Adiels, MR Taskinen, C Packard, MJ Caslake, A Soro-Paavonen, ... Diabetologia 49, 755-765, 2006 | 801 | 2006 |
The gut microbiota modulates host energy and lipid metabolism in mice [S] VR Velagapudi, R Hezaveh, CS Reigstad, P Gopalacharyulu, L Yetukuri, ... Journal of lipid research 51 (5), 1101-1112, 2010 | 682 | 2010 |
The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management RA Hegele, HN Ginsberg, MJ Chapman, BG Nordestgaard, ... The lancet Diabetes & endocrinology 2 (8), 655-666, 2014 | 663 | 2014 |
The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of European descent RM Mancina, P Dongiovanni, S Petta, P Pingitore, M Meroni, R Rametta, ... Gastroenterology 150 (5), 1219-1230. e6, 2016 | 658 | 2016 |
Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease P Dongiovanni, S Petta, C Maglio, AL Fracanzani, R Pipitone, E Mozzi, ... Hepatology 61 (2), 506-514, 2015 | 581 | 2015 |
Plant sterols and plant stanols in the management of dyslipidaemia and prevention of cardiovascular disease H Gylling, J Plat, S Turley, HN Ginsberg, L Ellegård, W Jessup, PJ Jones, ... Atherosclerosis 232 (2), 346-360, 2014 | 573 | 2014 |
The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis: a triumph of simplicity J Borén, KJ Williams Current opinion in lipidology 27 (5), 473-483, 2016 | 516 | 2016 |
New insights into the pathophysiology of dyslipidemia in type 2 diabetes MR Taskinen, J Borén Atherosclerosis 239 (2), 483-495, 2015 | 504 | 2015 |
Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus … HN Ginsberg, CJ Packard, MJ Chapman, J Borén, CA Aguilar-Salinas, ... European heart journal 42 (47), 4791-4806, 2021 | 488 | 2021 |